文献速递核素与放射性配体治疗肿瘤 PET/CT

全身Biograph Vision Quadra PET/CT用于90Y放射性栓塞术后临床评估:图像质量、肿瘤、肝脏与肺剂量学

90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-02-13

本研究纳入17例肝细胞癌患者,中位注射活度2393 MBq,利用全身Biograph Vision Quadra PET/CT评估90Y肝放射性栓塞术后临床数据,探索扫描时间与剂量学方案优化潜力。结果显示,与20分钟标准扫描相比,模拟5分钟重建图像在峰值SNR和噪声表现上相当,肿瘤、全肝和肺吸收剂量的治疗后剂量学表现也相似。

要点

  • 20分钟与5分钟重建时间在峰值SNR、变异系数和病灶本底比上无统计学显著差异。
  • 20分钟与1分钟重建时间在所有剂量学指标上均无统计学显著差异。
  • 基于Simplicit90Y的肿瘤吸收剂量与预期相似,HERMES则持续显著低估实测肿瘤吸收剂量。

核心结论

  • 与20分钟标准扫描相比,模拟5分钟重建图像提供了相等的图像峰值SNR和噪声表现,在肿瘤、全肝和肺吸收剂量的治疗后剂量学方面表现也相似。

研究设计与样本

  • 本研究纳入17例肝细胞癌患者,中位(IQR)注射活度为2393(1348-3298)MBq。
  • 治疗前剂量学计划基于99mTc-MAA SPECT/CT并结合Simplicit90Y™,治疗后分别用Quadra结合Simplicit90Y™和HERMIA独立验证。
  • 图像重建采用20、15、10、5和1分钟正弦图,迭代次数为2、4、6和8次。
  • 使用Wilcoxon符号秩检验显示统计学显著性(p < 0.05)。

主要发现

  • 20分钟与5分钟重建时间在峰值SNR、变异系数(COV)和病灶本底比(LBR)上无统计学显著差异。
  • 20分钟与1分钟重建时间在所有剂量学指标上均无统计学显著差异。
  • 肺剂量学显示值持续低于预期值。
  • 基于Simplicit90Y™的肿瘤吸收剂量与预期相似,而HERMES持续显著低估实测肿瘤吸收剂量。
  • 预期与实测的肿瘤、全肝和肺剂量在所有重建时间上均无统计学显著差异。

关键数值与推荐

  • 图像质量评估指标包括平均和峰值SNR、变异系数(COV)和病灶本底比(LBR)。
  • 治疗后剂量学验证采用Simplicit90Y和HERMES评估平均肿瘤、全肝和肺吸收剂量。
  • 统计学显著性设定为p < 0.05,使用Wilcoxon符号秩检验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Evaluation of 90Y liver radioembolization post-treatment clinical data using a whole-body Biograph Vision Quadra PET/CT to investigate the potential of protocol optimization in terms of scan time and dosimetry. METHODS: 17 patients with hepatocellular carcinoma with median (IQR) injected activity 2393 (1348-3298) MBq were included. Pre-treatment dosimetry plan was based on 99mTc-MAA SPECT/CT with Simplicit90Y™ and post-treatment validation with Quadra using Simplicit90Y™ and HERMIA independently. Regarding the image analysis, mean and peak SNR, the coefficient of variation (COV) and lesion-to-background ratio (LBR) were evaluated. For the post-treatment dosimetry validation, the mean tumor, whole liver and lung absorbed dose evaluation was performed using Simplicit90Y and HERMES. Images were reconstructed with 20-, 15-, 10-, 5- and 1- min sinograms with 2, 4, 6 and 8 iterations. Wilcoxon signed rank test was used to show statistical significance (p < 0.05). RESULTS: There was no difference of statistical significance between 20- and 5- min reconstructed times for the peak SNR, COV and LBR. In addition, there was no difference of statistical significance between 20- and 1- min reconstructed times for all dosimetry metrics. Lung dosimetry showed consistently lower values than the expected. Tumor absorbed dose based on Simplicit90Y™ was similar to the expected while HERMES consistently underestimated significantly the measured tumor absorbed dose. Finally, there was no difference of statistical significance between expected and measured tumor, whole liver and lung dose for all reconstruction times. CONCLUSION: In this study we evaluated, in terms of image quality and dosimetry, whole-body PET clinical images of patients after having been treated with 90Y microspheres radioembolization for liver cancer. Compared to the 20-min standard scan, the simulated 5-min reconstructed images provided equal image peak SNR and noise behavior, while performing also similarly for post-treatment dosimetry of tumor, whole liver and lung absorbed doses.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zeimpekis KG, Mercolli L, Conti M, et al. 90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry. Eur J Nucl Med Mol Imaging. 2024. PMID: 38347299. doi:10.1007/s00259-024-06650-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。